SCHEMBL29424329

SCHEMBL29424329

C1=Cc2c([nH]c3ccccc23)CN1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
NR2E1 Q9Y466 2/20 0.42
HTR5A P47898 1/20 0.42
NISCH Q9Y2I1 1/20 0.42
ALDH1A1 P00352 3/20 0.41
GPR3 P46089 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
CHRNA7 P36544 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
AHR P35869 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
PARP1 P09874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL465036 1.00 KDM4E (0.42) KDM4ENR2E1HTR5ANISCHALDH1A1
SCHEMBL223751 0.81 ALDH1A1 (0.50) KDM4ENR2E1HTR5ANISCHALDH1A1
SCHEMBL454277 0.70 HTR2A (0.43) KDM4ENR2E1HTR5ANISCHALDH1A1
SCHEMBL4127395 0.70 KDM4E (0.42) KDM4ENR2E1HTR5ANISCHALDH1A1
SCHEMBL2072294 0.70 KDM4E (0.50) KDM4ENR2E1HTR5ANISCHALDH1A1
SCHEMBL4437258 0.69 ALDH1A1 (0.40) KDM4ENR2E1HTR5ANISCHALDH1A1
SCHEMBL21668867 0.69 KDM4E (0.41) KDM4ENR2E1HTR5ANISCHALDH1A1
SCHEMBL3925948 0.69 KDM4E (0.41) KDM4ENR2E1HTR5ANISCHALDH1A1
SCHEMBL7078918 0.69 KDM4E (0.44) KDM4EALDH1A1GPR3HSD17B10HTR2A
SCHEMBL27741230 0.69 KDM4E (0.41) KDM4ENR2E1HTR5ANISCHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3915987-B1 ALKYL-AMINE HARMINE DERIVATIVES FOR PROMOTING BONE GROWTH OSTEOQC INC (CA) 2023-12-13 EP disclosed
CN-113462662-B Enzyme for preparing chiral tetrahydro beta-carboline and preparation method and application thereof 上海交通大学 2022-11-11 CN disclosed
US-11267814-B2 Compounds for bone growth OsteoQC, Inc. 2022-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11267814-B2 Compounds for bone growth FGF1, FGF2, BMP2 KDM4E 2795/4885NR2E1 1184/4885HTR5A 3288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.